| abstract |
According to the present invention, alveolar parenchyma in which 0.004-200 g / season of the film-forming component per time, preferably 0.07-20 g / season, more preferably 0.5-5 g / season of the film-forming component is embodied in the respiratory area of human It is an object of the present invention to provide a medicament for reducing the dose of alveoli or alveolar cysts embodied by a respiratory volume inhibitor which forms a film in the respiratory area mainly composed of film formation. |